Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0601BD02 Fuc-GM1(d18:1/18:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1691.93 C79H141N3O35
LMSP0601BD03 Fuc-GM1(d18:1/20:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1719.97 C81H145N3O35
LMSP0601BD04 Fuc-GM1(d18:1/22:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1748 C83H149N3O35
LMSP0601BD05 Fuc-GM1(d18:1/24:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1776.03 C85H153N3O35
LMSP0601BD07 Fuc-GM1(d18:1/24:1(15Z)) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1774.01 C85H151N3O35
LMSP0601BD06 Fuc-GM1(d18:1/26:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1804.06 C87H157N3O35
LMSP0601BD08 Fuc-GM1(d18:1/26:1(17Z)) Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1802.04 C87H155N3O35
LMSP0601EI01 G6 ganglioside(d18:1/16:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1882.98 C85H150N4O41
LMSP0601EI02 G6 ganglioside(d18:1/18:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1911.01 C87H154N4O41
LMSP0601EI03 G6 ganglioside(d18:1/20:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1939.04 C89H158N4O41
LMSP0601EI04 G6 ganglioside(d18:1/22:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1967.07 C91H162N4O41
LMSP0601EI05 G6 ganglioside(d18:1/24:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1995.1 C93H166N4O41
LMSP0601EI07 G6 ganglioside(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1993.09 C93H164N4O41
LMSP0601EI06 G6 ganglioside(d18:1/26:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2023.13 C95H170N4O41
LMSP0601EI08 G6 ganglioside(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2021.12 C95H168N4O41
LMSP0601BV01 GD1a (NeuAc/NeuGc)(d18:1/16:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1824.94 C82H144N4O40
LMSP0601BV02 GD1a (NeuAc/NeuGc)(d18:1/18:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1852.97 C84H148N4O40
LMSP0601BV03 GD1a (NeuAc/NeuGc)(d18:1/20:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1881 C86H152N4O40
LMSP0601BV04 GD1a (NeuAc/NeuGc)(d18:1/22:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1909.03 C88H156N4O40
LMSP0601BV05 GD1a (NeuAc/NeuGc)(d18:1/24:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1937.06 C90H160N4O40
LMSP0601BV07 GD1a (NeuAc/NeuGc)(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1935.05 C90H158N4O40
LMSP0601BV06 GD1a (NeuAc/NeuGc)(d18:1/26:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1965.09 C92H164N4O40
LMSP0601BV08 GD1a (NeuAc/NeuGc)(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1963.08 C92H162N4O40
LMSP0601CQ01 GD1a (NeuGc/NeuGc)(d18:1/16:0) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1840.93 C82H144N4O41
LMSP0601CQ02 GD1a (NeuGc/NeuGc)(d18:1/18:0) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1868.96 C84H148N4O41
LMSP0601CQ03 GD1a (NeuGc/NeuGc)(d18:1/20:0) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1896.99 C86H152N4O41
LMSP0601CQ04 GD1a (NeuGc/NeuGc)(d18:1/22:0) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1925.02 C88H156N4O41
LMSP0601CQ05 GD1a (NeuGc/NeuGc)(d18:1/24:0) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1953.06 C90H160N4O41
LMSP0601CQ07 GD1a (NeuGc/NeuGc)(d18:1/24:1(15Z)) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1951.04 C90H158N4O41
LMSP0601CQ06 GD1a (NeuGc/NeuGc)(d18:1/26:0) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1981.09 C92H164N4O41
LMSP0601CQ08 GD1a (NeuGc/NeuGc)(d18:1/26:1(17Z)) NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1979.07 C92H162N4O41
LMSP0601AS01 GD1a(d18:1/16:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1808.94 C82H144N4O39
LMSP0601AS02 GD1a(d18:1/18:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1836.97 C84H148N4O39
LMSP0601AS03 GD1a(d18:1/20:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1865 C86H152N4O39
LMSP0601AS04 GD1a(d18:1/22:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1893.03 C88H156N4O39
LMSP0601AS05 GD1a(d18:1/24:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1921.07 C90H160N4O39
LMSP0601AS07 GD1a(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1919.05 C90H158N4O39
LMSP0601AS06 GD1a(d18:1/26:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1949.1 C92H164N4O39
LMSP0601AS08 GD1a(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1947.08 C92H162N4O39
LMSP0601BE01 GD1aa(d18:1/16:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1808.94 C82H144N4O39
LMSP0601BE02 GD1aa(d18:1/18:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1836.97 C84H148N4O39
LMSP0601BE03 GD1aa(d18:1/20:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1865 C86H152N4O39
LMSP0601BE04 GD1aa(d18:1/22:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1893.03 C88H156N4O39
LMSP0601BE05 GD1aa(d18:1/24:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1921.07 C90H160N4O39
LMSP0601BE07 GD1aa(d18:1/24:1(15Z)) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1919.05 C90H158N4O39
LMSP0601BE06 GD1aa(d18:1/26:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1949.1 C92H164N4O39
LMSP0601BE08 GD1aa(d18:1/26:1(17Z)) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1947.08 C92H162N4O39
LMSP0601AQ01 GD1b(d18:1/16:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1808.94 C82H144N4O39
LMSP0601AQ02 GD1b(d18:1/18:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1836.97 C84H148N4O39
LMSP0601AQ03 GD1b(d18:1/20:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1865 C86H152N4O39